Recruiting MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia NCT07371403 Conditions Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic Leukemia Recurrent, +13 more Locations King Hussein Cancer Center — Amman, Jordan View Trial Details
Recruiting Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies NCT05705570 Conditions Acute Lymphoblastic Leukemia Refractory, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +14 more Locations Hospital Israelita Albert Einstein — São Paulo, Brazil View Trial Details
